ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,162,000 | -46.9% | 32,600 | -38.5% | 0.02% | -42.9% |
| Q4 2020 | $4,069,000 | +57.4% | 53,026 | -11.7% | 0.03% | +55.6% |
| Q3 2020 | $2,585,000 | -7.1% | 60,026 | -6.8% | 0.02% | -18.2% |
| Q2 2020 | $2,783,000 | +74.5% | 64,426 | +16.2% | 0.02% | +46.7% |
| Q1 2020 | $1,595,000 | -56.1% | 55,426 | -3.3% | 0.02% | -40.0% |
| Q4 2019 | $3,636,000 | +91.9% | 57,326 | -14.7% | 0.02% | +108.3% |
| Q3 2019 | $1,895,000 | -1.6% | 67,226 | -7.4% | 0.01% | -7.7% |
| Q2 2019 | $1,925,000 | +218.2% | 72,626 | +120.1% | 0.01% | +225.0% |
| Q1 2019 | $605,000 | +47.9% | 33,000 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $409,000 | – | 33,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |